Singapore Reports First Case of Blindness Caused by Injection of Aesthetic Dermal Filler
- Brief Intermittent Exercise Reduces Heart Disease and Death Risk
- Personalized Lung Tumor Chips Assess PD-1 Therapy Response
- Study Shows Prior Infection Offers Strong Immunity to Original COVID-19 Strain
- Chinese Food Products Dominate Korean Tables Amid Safety Concerns
- Early Detection of Hypopharyngeal Cancer Possible with Saliva Diagnosis
- EB Virus Could Be Infected by Kiss: A Hidden Threat Linked to Cancer
Singapore Reports First Case of Blindness Caused by Injection of Aesthetic Dermal Filler
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Singapore Reports First Case of Blindness Caused by Injection of Aesthetic Dermal Filler.
Singapore has witnessed its first case of blindness caused by the injection of a medical aesthetic dermal filler, leading to vascular occlusion.
The Singapore Health Sciences Authority (HSA) has confirmed receiving a report of this incident but emphasized that there has not been a significant increase in reports of severe adverse reactions due to medical aesthetic implants.
Authorities are currently investigating whether there are any safety or quality concerns with related products from the same batch and will take necessary actions if issues are identified.
In response to queries from Channel NewsAsia, the HSA stated that they received a notification from the medical aesthetics product company Parvus(S) on July 29th, reporting a case of injection involving the dermal filler known as AestheFill.
This dermal filler was registered locally on October 1, 2021, and its primary purpose is to improve facial wrinkles. Dermal fillers of this nature are classified as Class D medical devices locally, indicating the highest level of risk.
Vascular occlusion leading to blindness is typically listed as a potential severe adverse reaction in the usage instructions for such products.
Other common side effects of using dermal fillers include redness, the formation of lumps under the skin, skin warmth, and temporary blurred vision.
Clinical practitioners administering dermal fillers are required to undergo specialized training provided by the relevant companies. Authorities recommend that consumers discuss risks and suitability with their healthcare provider before undergoing injections.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
